APA (7th ed.) Citation

Hironao Okubo, Hitoshi Ando, Kei Ishizuka, Jun-ichi Morishige, Kenichi Ikejima, Shuichiro Shiina, & Akihito Nagahara. (2022). Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma. Elsevier.

Chicago Style (17th ed.) Citation

Hironao Okubo, Hitoshi Ando, Kei Ishizuka, Jun-ichi Morishige, Kenichi Ikejima, Shuichiro Shiina, and Akihito Nagahara. Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Lenvatinib in Patients with Hepatocellular Carcinoma. Elsevier, 2022.

MLA (9th ed.) Citation

Hironao Okubo, et al. Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Lenvatinib in Patients with Hepatocellular Carcinoma. Elsevier, 2022.